FocalTherics
™
to Announce Second Quarter 2026 Financial Results on August 13, 2026
Company to host conference call and webcast on Thursday, August 13 at 4:30 p.m. EDT
AUSTIN, Texas, July 30, 2026 (GLOBE NEWSWIRE) -- FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it will release its financial results for the second quarter ended June 30, 2026, after market close on Thursday, August 13, 2026.
An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer, and François Dietsch, Chief Accounting Officer. Please refer to the information below for conference call dial-in information and webcast registration.
Call Details:
|
Date:
|
Thursday, August 13, 2026, at 4:30 p.m. Eastern Time
|
|
Domestic:
|
1-800-245-3047
|
|
International:
|
1-203-518-9765
|
|
Passcode:
|
FOCAL
|
|
Webcast:
|
https://viavid.webcasts.com/starthere.jsp?ei=1767672&tp_key=2d69d92ca7
|
About FocalTherics
A recognized global leader in Robotic Focal Therapy, FocalTherics develops, manufactures, and markets minimally invasive medical devices worldwide to treat various conditions using proprietary focused ultrasound technology. The Company’s flagship platform, Focal One Robotic HIFU, combines advanced imaging, real-time treatment planning, robotic precision, and HIFU technology to deliver personalized focal therapy designed to optimize clinical outcomes while preserving quality of life. FocalTherics is committed to expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and global market development initiatives. For more information about FocalTherics, visit
FocalTherics.com
.
Investor Contacts
Louisa Smith
Gilmartin Group
investor.relations@focalone.com
View the Zacks #1 Rank List
FocalTherics to Report Second Quarter 2026 Financial Results on August 13
FocalTherics will release Q2 2026 financial results and hold a conference call on August 13, 2026.
Quiver AI Summary
FocalTherics, a leader in robotic focal therapy, announced that it will release its financial results for the second quarter of 2026 on August 13, after market close. The company will host a conference call and webcast on the same day at 4:30 p.m. EDT featuring CEO Ryan Rhodes, CFO Ken Mobeck, and Chief Accounting Officer François Dietsch. They invite investors to participate using the provided dial-in numbers and webcast link. FocalTherics is known for its minimally invasive medical devices that utilize advanced focused ultrasound technology, aiming to enhance clinical outcomes while maintaining patients' quality of life. For more details about the company, interested parties can visit its website.
Potential Positives
Potential Negatives
FAQ
When will FocalTherics announce its financial results?
FocalTherics will announce its financial results for Q2 2026 on August 13, 2026, after market close.
What time is the FocalTherics conference call?
The conference call will take place at 4:30 p.m. EDT on August 13, 2026.
How can I access the FocalTherics webcast?
You can access the FocalTherics webcast at https://viavid.webcasts.com/starthere.jsp?ei=1767672&tp_key=2d69d92ca7.
Who will lead the FocalTherics conference call?
The conference call will be led by CEO Ryan Rhodes and CFO Ken Mobeck.
What is FocalTherics known for?
FocalTherics is known for developing robotic focal therapy and advanced minimally invasive medical devices.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$FOCL Hedge Fund Activity
We have seen 1 institutional investors add shares of $FOCL stock to their portfolio, and 2 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
FocalTherics ™ to Announce Second Quarter 2026 Financial Results on August 13, 2026
Company to host conference call and webcast on Thursday, August 13 at 4:30 p.m. EDT
AUSTIN, Texas, July 30, 2026 (GLOBE NEWSWIRE) -- FocalTherics (Nasdaq: FOCL) (the “Company”), the global leader in robotic focal therapy, today announced that it will release its financial results for the second quarter ended June 30, 2026, after market close on Thursday, August 13, 2026.
An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer, and François Dietsch, Chief Accounting Officer. Please refer to the information below for conference call dial-in information and webcast registration.
Call Details:
About FocalTherics
A recognized global leader in Robotic Focal Therapy, FocalTherics develops, manufactures, and markets minimally invasive medical devices worldwide to treat various conditions using proprietary focused ultrasound technology. The Company’s flagship platform, Focal One Robotic HIFU, combines advanced imaging, real-time treatment planning, robotic precision, and HIFU technology to deliver personalized focal therapy designed to optimize clinical outcomes while preserving quality of life. FocalTherics is committed to expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and global market development initiatives. For more information about FocalTherics, visit FocalTherics.com .
Investor Contacts
Louisa Smith
Gilmartin Group
investor.relations@focalone.com
Read full article here »